Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Medical Countermeasures Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic FeverGlobal Biodefense StaffJune 5, 2025
Notable Contracts: DTRA Small Molecule Countermeasures Research Medical Countermeasures April 10, 2014 …
Rapid, Broad Countermeasures Sought Against Mystery Infections Medical Countermeasures April 8, 2014 …
Pharmocogenomics Has Not Fulfilled Its Promise to Developing Countries Medical Countermeasures April 4, 2014 …
UGA Awarded Grand Challenges Funding for Rotavirus Vaccine Research Medical Countermeasures April 1, 2014 …
USAMRIID Seeks Animal Vaccination Services for Immunogenicity Studies Contracts + Grants March 31, 2014 …
Bacterial Reporters Pave the Way to Living Diagnostics and Therapeutics Medical Countermeasures March 28, 2014 …
BARDA Awards Medical Countermeasure Clinical Studies Network Contracts Industry News March 26, 2014 …
RFI – Optimizing Therapeutic Compounds against Priority Pathogens Contracts + Grants March 25, 2014 …
Sanford Applied Biosciences Supporting VEE Countermeasure Research Defense + Military March 24, 2014 …
